Page 146 | Certara

Poster

Prediction of mAb disposition in hepatic impairment – Evolocumab as a case study

CertaraOctober 15, 2019

Poster

Use of a physiologically based pharmacokinetic – pharmacodynamic (PBPK-PD) model to guide dose adjustments to S-warfarin in different populations

CertaraOctober 15, 2019

Poster

Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed PBPK Model of Ritonavir Norvir® Tablet Absorption in Humans Under Fasted and Fed State Conditions

CertaraOctober 15, 2019

Poster

Accounting for CYP2C19 mechanism based inhibition and CYP1A2 induction in a PBPK model for omeprazole

CertaraOctober 11, 2019

Poster

Physiological verification of a geriatric population using the Simcyp R package

CertaraOctober 11, 2019

Poster

Estimation of Effective pKa of Bicarbonate Buffer

CertaraOctober 11, 2019

Poster

Quantification of Human Blood-Brain Barrier Transporters in Health and in Dementia by Global and Targeted Proteomics

CertaraOctober 11, 2019

Poster

The Molecular Stethoscope: RNA of Drug Metabolising Enzymes in Circulating Vesicles Correlates with their Specific Protein Content in the Liver

CertaraOctober 11, 2019

Poster

Propofol: A Tail of Drug Disposition and Dynamics in Different Dog Breeds

CertaraOctober 11, 2019

Blog

Health Canada PRCI Guiding Principles and Observations

Health Canada released guidance on March 12, 2019 pertaining to its Public Release of Clinical…

CertaraSeptember 16, 2019

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy